Miroshnichenko II - Search Results

1

[Therapeutic drug monitoring of antipsychotic drugs in routine psychiatric practice].

Miroshnichenko II, Baymeeva NV, Platova AI, Kaleda VG. Miroshnichenko II, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(5):145-152. doi: 10.17116/jnevro2023123051145. Zh Nevrol Psikhiatr Im S S Korsakova. 2023. PMID: 37315254 Russian.

2

[Therapeutic drug monitoring of aripiprazole as part of the individualization of the pharmacotherapy of schizophrenia].

Baymeeva NV, Miroshnichenko II, Platova AI, Tikhonov DV, Kaleda VG. Baymeeva NV, et al. Among authors: miroshnichenko ii. Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(1):98-103. doi: 10.17116/jnevro202212201198. Zh Nevrol Psikhiatr Im S S Korsakova. 2022. PMID: 35175709 Russian.

3

[Neopterin as a potential biomarker in neuropsychiatry].

Shilov YE, Miroshnichenko II. Shilov YE, et al. Among authors: miroshnichenko ii. Zh Nevrol Psikhiatr Im S S Korsakova. 2020;120(10):125-129. doi: 10.17116/jnevro2020120101125. Zh Nevrol Psikhiatr Im S S Korsakova. 2020. PMID: 33244968 Russian.

4

Therapeutic Drug Monitoring of Olanzapine and Cytochrome P450 Genotyping in Nonsmoking Subjects.

Miroshnichenko II, Pozhidaev IV, Ivanova SA, Baymeeva NV. Miroshnichenko II, et al. Ther Drug Monit. 2020 Apr;42(2):325-329. doi: 10.1097/FTD.0000000000000695. Ther Drug Monit. 2020. PMID: 31425442

5

Haloperidol Reduces the Activity of Complement and Induces the Anti-Inflammatory Transformation of Peritoneal Macrophages in Rats.

Cheremnykh EG, Ivanov PA, Sokolov OY, Prokhorova TA, Tereshkina EB, Baymeeva NV, Miroshnichenko II, Kost NV. Cheremnykh EG, et al. Among authors: miroshnichenko ii. J Neuroimmune Pharmacol. 2019 Sep;14(3):369-374. doi: 10.1007/s11481-019-09860-3. Epub 2019 Jul 6. J Neuroimmune Pharmacol. 2019. PMID: 31280407

6

[The content of N-acetylaspartate in depressed elderly patients during therapy with antidepressants and actovegin].

Miroshnichenko II, Yakovleva OB, Safarova TP, Shipilova ES, Baymeeva NV. Miroshnichenko II, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(4):38-42. doi: 10.17116/jnevro201911904138. Zh Nevrol Psikhiatr Im S S Korsakova. 2019. PMID: 31156220 Russian.

7

[Therapeutic drug monitoring of risperidone and its active metabolite 9-hydroxyrisperidone in the treatment of schizophrenia].

Baymeeva NV, Platova AI, Kaleda VG, Miroshnichenko II. Baymeeva NV, et al. Among authors: miroshnichenko ii. Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(3):24-28. doi: 10.17116/jnevro201911903124. Zh Nevrol Psikhiatr Im S S Korsakova. 2019. PMID: 31089091 Russian.

8

Simultaneous Determination of Antipsychotic Drugs and Their Active Metabolites by LC-MS-MS and its Application to Therapeutic Drug Monitoring.

Miroshnichenko II, Baymeeva NV. Miroshnichenko II, et al. J Chromatogr Sci. 2018 Jul 1;56(6):510-517. doi: 10.1093/chromsci/bmy024. J Chromatogr Sci. 2018. PMID: 29635397

9

Genotyping and phenotyping of CYP2D6 and CYP3A isoenzymes in patients with alcohol use disorder: correlation with haloperidol plasma concentration.

Sychev DA, Zastrozhin MS, Miroshnichenko II, Baymeeva NV, Smirnov VV, Grishina EA, Ryzhikova KA, Mirzaev KB, Markov DD, Skryabin VY, Snalina NE, Nosikova PG, Savchenko LM, Bryun EA. Sychev DA, et al. Among authors: miroshnichenko ii. Drug Metab Pers Ther. 2017 Sep 26;32(3):129-136. doi: 10.1515/dmpt-2017-0021. Drug Metab Pers Ther. 2017. PMID: 28787271

10

[N-acetylaspartate is a biomarker of psychiatric and neurological disorders].

Baymeeva NV, Miroshnichenko II. Baymeeva NV, et al. Among authors: miroshnichenko ii. Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(8):94-98. doi: 10.17116/jnevro20151158194-98. Zh Nevrol Psikhiatr Im S S Korsakova. 2015. PMID: 26356622 Review. Russian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page